Welcome to our dedicated page for Trulieve Cannabis news (Ticker: TCNNF), a resource for investors and traders seeking the latest updates and insights on Trulieve Cannabis stock.
Trulieve Cannabis Corp. reports news about its U.S. cannabis operations, financial results, dispensary expansion, regulatory developments, and capital actions. The company is a vertically integrated multi-state cannabis operator with established hubs in the Northeast, Southeast, and Southwest, anchored by markets including Arizona, Florida, Ohio, and Pennsylvania. Its updates frequently cover retail sales, margins, cash flow, senior secured note financing, and medical cannabis store openings.
Company announcements also address medical marijuana regulation, including Schedule III rescheduling and DEA registration activity for state-licensed medical operations. Product-related news highlights Trulieve's in-house and partner cannabis brands offered through its dispensary network.
Trulieve Cannabis Corp. announced strategic acquisitions of PurePenn LLC and Solevo Wellness to enhance its presence in Pennsylvania, expanding its multi-state footprint. The transactions, valued at $46 million for PurePenn and $20 million for Solevo, will boost Trulieve's cultivation capabilities by adding 35,000 square feet of existing facilities, with plans for expansion. This move aims to solidify Trulieve's position in the rapidly growing Pennsylvania cannabis market, projected to reach $575 million by 2020. The acquisitions are expected to close in Q4 2020, contingent on regulatory approvals.
Trulieve Cannabis Corp. (OTCQX: TCNNF) opened its 60th dispensary nationwide and 58th in Florida, located in Tampa, on September 11, 2020. This new location aims to enhance patient access to medical cannabis in Hillsborough County, joining two other dispensaries in the Tampa area. To celebrate, a 25% discount is offered on opening day. Trulieve supports over 410,000 registered medical marijuana patients in Florida, serving nearly half of the state's overall volume. Customers can access a wide range of THC and CBD products, with options for online ordering, curbside pickup, and home delivery.
Trulieve Cannabis Corp. announced that CEO Kim Rivers will participate in virtual conferences: the 9th Annual Gateway Conference on September 9, 2020, and the Beacon Securities Cannabis Conference on September 10, 2020. Rivers will engage in a fireside chat at 1:00 p.m. EST and deliver a presentation at 2:00 p.m. EST, respectively. Both events will be webcast live and available for replay. Trulieve, a leading medical cannabis company based in Florida, is listed on the OTCQX under the symbol TCNNF.
Trulieve Cannabis Corp (OTCQX: TCNNF) made history in Florida by recording its first sale of edible cannabis, TruChocolate, on September 5, 2020, shortly after receiving state approval. This marks Trulieve's continued leadership in the cannabis market, offering a range of edible products including those from partner brand Love’s Oven. The company aims to enhance access to medication for Florida patients and has plans for broader distribution across its stores, showcasing a commitment to innovation and customer service.
Trulieve Cannabis Corp (OTCQX: TCNNF) has launched its first line of edible cannabis products in Florida, following approval from the Department of Health. This historic rollout took place at the Tallahassee dispensary, marking the first edible sale in the state. The company aims to enhance patient access to preferred medication formats, responding to years of demand. Initial offerings include TruGel in blue raspberry, with plans for additional flavors and collaborations with specialty brands. This move signifies a significant expansion in Trulieve's product offerings.
Trulieve Cannabis Corp. has opened its 59th dispensary in St. Petersburg, Florida, expanding access to medical cannabis for patients in Pinellas County. This new location, set to open on August 28, 2020, will offer a 25% discount to all patients visiting on opening day. Trulieve, a leading cannabis company, emphasizes a customer-driven retail experience. The company monitors safety protocols amidst the coronavirus pandemic and aims to provide patients with Florida's largest selection of THC and CBD products, available for online ordering and home delivery.
Trulieve Cannabis Corp (OTCQX: TCNNF) is launching a range of edible cannabis products in Florida, following new regulations from the Department of Health. This move addresses long-standing patient demands for more product options. The company has established a 10,000 sq. ft. kitchen in Quincy, FL, for production and testing of these edibles. Partners like Binske and Bhang will contribute to the product line. Trulieve anticipates significant sales from edibles, mirroring the success of its flower products, and recently reported Q2 2020 revenue of $120.8M.
Trulieve Cannabis Corp. announces the launch of two new flavors, Vanilla Cream and Lemon, for its TruPowder product line in Florida. TruPowder, a nano-encapsulated cannabinoid powder, utilizes advanced technology for increased bioavailability and quicker onset. These new flavors aim to enhance patient experience by expanding the product variety available in Trulieve's dispensaries across Florida. Trulieve continues to lead in providing high-quality cannabis products and offers a wide selection of delivery methods to patients.
Trulieve Cannabis Corp. announced the opening of its 58th dispensary in Longwood, Florida, marking its first location in Seminole County. This new dispensary aims to enhance patient access to medical cannabis in the state. Opening day is set for August 20, 2020, with a 25% discount for all patients. Trulieve continues to adapt to health guidelines amid the pandemic, with measures like curbside pickup and enhanced cleaning practices. The company remains a leader in Florida's medical cannabis market, catering to a growing patient base.